Fermer le menu


Member of Lyonbiopole


Valbiotis is a Research & Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases in response to unmet medical needs. Valbiotis has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of health nutrition products designed to reduce the risk of major metabolic diseases, relying on a multi-target strategy enabled by the use of plant-based terrestrial and marine resources. Its products are intended to be licensed to players in the health sector. Created at the beginning of 2014 in La Rochelle, the Company has forged numerous partnerships with leading academic centers. The Company has established three sites in France – Périgny, La Rochelle (17) and Riom (63) – and a subsidiary in Quebec City (Canada). Valbiotis is a member of the "BPI Excellence" network and has been recognized as an "Innovative Company" by the BPI label. Valbiotis has also been awarded "Young Innovative Company" status and has received major financial support from the European Union for its research programs via the European Regional Development Fund (ERDF). Valbiotis is a PEA-SME eligible company.


Strategic application domain: Human Medicine

Application market: Cardiology, Metabolic Disorders - Endocrinology, Nutritional Prévention

Type of activity: Nutrition & Health products

Technologies: Animal model & In vivo testing, in vitro & Ex Vivo model, Others

Created on jan. 1st, 2014 - 49 employees



12F, Rue Paul Vatine 17180 Périgny



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.